Abstract
The national guidelines for treatment of chronic coronary heart disease (CHD) recommend surgical coronary aortic bypass grafting (CABG) rather than percutaneous coronary intervention (PCI) for patients with a coronary three-vessel disease. The epidemiology of three-vessel CHD and data about the application of different revascularisation strategies raise suspicion of deviation from the guidelines in the treatment of those patients. Claims data containing records of almost 10 million patients of the largest German statutory health insurance fund (Techniker Krankenkasse) were utilised to measure adherence to the guidelines for treatment of groups of patients with one-, two-, and three-vessel CHD, respectively. The impact of age, sex, and comorbidity on each patient’s revascularisation procedure was investigated as well. There was no significant difference in the rate of PCI between the groups. In conclusion, the hypothesis that patients with a coronary three-vessel disease are not always treated according to the recommendations of the national guidelines could not be disproved by this study. Finally, the results of this study suggest that the best revascularisation strategy for each patient with two- and three-vessel disease should be decided upon by an interdisciplinary discussion between both cardiologists and cardiac surgeons.
Similar content being viewed by others
References
Benedetto, U., Gaudino, M., Ng, C., Biondi-Zoccai, G., D’Ascenzo, F., Frati, G., Girardi, L.N., Angelini, G.D., Taggart, D.P.: Coronary surgery is superior to drug eluting stents in multivessel disease. Systematic review and meta-analysis of contemporary randomized controlled trials. Int. J. Cardiol. 210, 19–24 (2016). doi:10.1016/j.ijcard.2016.02.090
Mohr, F.W., Morice, M.C., Kappetein, A.P., Feldman, T.E., Stahle, E., Colombo, A., Mack, M.J., Holmes Jr., D.R., Morel, M.A., van Dyck, N., Houle, V.M., Dawkins, K.D., Serruys, P.W.: Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 381(9867), 629–638 (2013)
Weintraub, W.S., Grau-Sepulveda, M.V., Weiss, J.M., O’Brien, S.M., Peterson, E.D., Kolm, P., Zhang, Z., Klein, L.W., Shaw, R.E., McKay, C., Ritzenthaler, L.L., Popma, J.J., Messenger, J.C., Shahian, D.M., Grover, F.L., Mayer, J.E., Shewan, C.M., Garratt, K.N., Moussa, I.D., Dangas, G.D., Edwards, F.H.: Comparative effectiveness of revascularization strategies. N. Engl. J. Med. 366(16), 1467–1476 (2012)
Kappetein, A.P., Feldman, T.E., Mack, M.J., Morice, M.C., Holmes, D.R., Stahle, E., Dawkins, K.D., Mohr, F.W., Serruys, P.W., Colombo, A.: Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur. Heart J. 32(17), 2125–2134 (2011)
Serruys, P.W., Morice, M.C., Kappetein, A.P., Colombo, A., Holmes, D.R., Mack, M.J., Stahle, E., Feldman, T.E., van den Brand, M., Bass, E.J., Van, D.N., Leadley, K., Dawkins, K.D., Mohr, F.W.: Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N. Engl. J. Med. 360(10), 961–972 (2009)
Authors/Task Force, m, Windecker, S., Kolh, P., Alfonso, F., Collet, J.P., Cremer, J., Falk, V., Filippatos, G., Hamm, C., Head, S.J., Juni, P., Kappetein, A.P., Kastrati, A., Knuuti, J., Landmesser, U., Laufer, G., Neumann, F.J., Richter, D.J., Schauerte, P., Sousa Uva, M., Stefanini, G.G., Taggart, D.P., Torracca, L., Valgimigli, M., Wijns, W., Witkowski, A.: 2014 ESC/EACTS guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur. Heart J. 35(37), 2541–2619 (2014). doi:10.1093/eurheartj/ehu278
Biancari, F., Myllyl, M., Lepojrvi, S., Kuttila, K., Porela, P., Laitio, T., Ylitalo, A., Jokinen, V., Luokkala, A., Airaksinen, K.E.: Preoperative warfarin treatment and outcome of coronary artery bypass graft surgery. Ann. Thorac. Surg. 89(4), 1139–1145 (2010)
Cohen, D.J., Lavelle, T.A., Van Hout, B., Li, H., Lei, Y., Robertus, K., Pinto, D., Magnuson, E.A., McGarry, T.F., Lucas, S.K., Horwitz, P.A., Henry, C.A., Serruys, P.W., Mohr, F.W., Kappetein, A.P.: Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: one-year results from the SYNTAX trial. Catheter. Cardiovasc. Interv. 79(2), 198–209 (2012)
Serruys, P.W., Unger, F., Sousa, J.E., Jatene, A., Bonnier, H.J., Schonberger, J.P., Buller, N., Bonser, R., van den Brand, M.J., van Herwerden, L.A., Morel, M.A., van Hout, B.A.: Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N. Engl. J. Med. 344(15), 1117–1124 (2001)
Bundesärztekammer, Kassenärztliche, B., Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen, F.: Nationale VersorgungsLeitlinie Chronische KHK—Langfassung, vol. 2. Aerztliches Zentrum fuer Qualitaet in der Medizin, Berlin (2013)
Beckmann, A., Funkat, A.K., Lewandowski, J., Frie, M., Schiller, W., Hekmat, K., Gummert, J.F., Mohr, F.W.: Cardiac surgery in Germany during 2012: a report on behalf of the German Society for Thoracic and Cardiovascular Surgery. Thorac. Cardiovasc. Surg. 62(1), 5–17 (2014)
Bruckenberger, E.: Multidisciplinary health report on cardiology and cardiac surgery, vol. 25. Deutsche Herzstiftung, Hannover (2013)
Kimura, T., Morimoto, T., Furukawa, Y., Nakagawa, Y., Kadota, K., Iwabuchi, M., Shizuta, S., Shiomi, H., Tada, T., Tazaki, J., Kato, Y., Hayano, M., Abe, M., Tamura, T., Shirotani, M., Miki, S., Matsuda, M., Takahashi, M., Ishii, K., Tanaka, M., Aoyama, T., Doi, O., Hattori, R., Tatami, R., Suwa, S., Takizawa, A., Takatsu, Y., Takahashi, M., Kato, H., Takeda, T., Lee, J.D., Nohara, R., Ogawa, H., Tei, C., Horie, M., Kambara, H., Fujiwara, H., Mitsudo, K., Nobuyoshi, M., Kita, T.: Long-term safety and efficacy of sirolimus-eluting stents versus bare-metal stents in real world clinical practice in Japan. Cardiovasc. Interv. Ther. 26(3), 234–245 (2011)
Schilling, T., Haverich, A.: The contradictory contexts of interdisciplinarity. Chirurg 83(4), 332–338 (2012)
Morice, M.C., Serruys, P.W., Kappetein, A.P., Feldman, T.E., Stahle, E., Colombo, A., Mack, M.J., Holmes, D.R., Choi, J.W., Ruzyllo, W., Religa, G., Huang, J., Roy, K., Dawkins, K.D., Mohr, F.: Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the SYNTAX trial. Circulation 129(23), 2388–2394 (2014)
Statistisches, B.: Bevoelkerung und Erwerbstaetigkeit. Bev”lkerungsfortschreibung. Statistisches Bundesamt, Wiesbaden (2013)
Elixhauser, A., Steiner, C., Harris, D.R., Coffey, R.M.: Comorbidity measures for use with administrative data. Med. Care 36(1), 8–27 (1998)
Quan, H., Sundararajan, V., Halfon, P., Fong, A., Burnand, B., Luthi, J.C., Saunders, L.D., Beck, C.A., Feasby, T.E., Ghali, W.A.: Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med. Care 43(11), 1130–1139 (2005)
van Walraven, C., Austin, P.C., Jennings, A., Quan, H., Forster, A.J.: A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med. Care 47(6), 626–633 (2009)
Kappetein, A.P., Head, S.J., Morice, M.C., Banning, A.P., Serruys, P.W., Mohr, F.W., Dawkins, K.D., Mack, M.J.: Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial. Eur. J. Cardiothorac. Surg. 43(5), 1006–1013 (2013)
Serruys, P.W., Ong, A.T., van Herwerden, L.A., Sousa, J.E., Jatene, A., Bonnier, J.J., Schonberger, J.P., Buller, N., Bonser, R., Disco, C., Backx, B., Hugenholtz, P.G., Firth, B.G., Unger, F.: Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J. Am. Coll. Cardiol. 46(4), 575–581 (2005)
Tazaki, J., Shiomi, H., Morimoto, T., Imai, M., Yamaji, K., Sakata, R., Okabayashi, H., Hanyu, M., Shimamoto, M., Nishiwaki, N., Komiya, T., Kimura, T.: Three-year outcome after percutaneous coronary intervention and coronary artery bypass grafting in patients with triple-vessel coronary artery disease: observations from the CREDO-Kyoto PCI/CABG registry cohort-2. EuroIntervention 9(4), 437–445 (2013)
Thiem, A., Attmann, T., Cremer, J.: Moderne Koronarchirurgie in Zusammenhang mit der SYNTAX-Studie und aktuellen Leitlinien. Herz 36(8), 669–676 (2011)
Maier, W., Camici, P., Windecker, S., Pfiffner, D., Wijns, W., Meier, B.: The European registry of cardiac catheter interventions 1997. Eur. Heart J. 23(24), 1903–1907 (2002)
van Buuren, F., Horstkotte, D.: 24th report about the statistics of the heart catheterization laboratory in the German Federal Republic. Results of the joint inquiry of the Commission for Clinical Cardiology and of the Working Groups for Interventional Cardiology and Angiology of the German Society for Cardiology and Circulatory Research in the year 2007. Kardiologie 3, 512–518 (2009)
Hoffmann, F., Icks, A.: Unterschiede in der Versichertenstruktur von Krankenkassen und deren Auswirkungen für die Versorgungsforschung: Ergebnisse des Bertelsmann-Gesundheitsmonitors. Gesundheitswesen 74(5), 291–297 (2012)
Go, A.S., Mozaffarian, D., Roger, V.L., Benjamin, E.J., Berry, J.D., Borden, W.B., Bravata, D.M., Dai, S., Ford, E.S., Fox, C.S., Franco, S., Fullerton, H.J., Gillespie, C., Hailpern, S.M., Heit, J.A., Howard, V.J., Huffman, M.D., Kissela, B.M., Kittner, S.J., Lackland, D.T., Lichtman, J.H., Lisabeth, L.D., Magid, D., Marcus, G.M., Marelli, A., Matchar, D.B., McGuire, D.K., Mohler, E.R., Moy, C.S., Mussolino, M.E., Nichol, G., Paynter, N.P., Schreiner, P.J., Sorlie, P.D., Stein, J., Turan, T.N., Virani, S.S., Wong, N.D., Woo, D., Turner, M.B.: Heart disease and stroke statistics–2013 update: a report from the American Heart Association. Circulation 127(1), e6–e245 (2013)
Lange, C.: Daten und Fakten: Ergebnisse der Studie “Gesundheit in Deutschland aktuell 2010”. Berlin (2012)
Farkouh, M.E., Domanski, M., Sleeper, L.A., Siami, F.S., Dangas, G., Mack, M., Yang, M., Cohen, D.J., Rosenberg, Y., Solomon, S.D., Desai, A.S., Gersh, B.J., Magnuson, E.A., Lansky, A., Boineau, R., Weinberger, J., Ramanathan, K., Sousa, J.E., Rankin, J., Bhargava, B., Buse, J., Hueb, W., Smith, C.R., Muratov, V., Bansilal, S., King 3rd, S., Bertrand, M., Fuster, V., Investigators, F.T.: Strategies for multivessel revascularization in patients with diabetes. N. Engl. J. Med. 367(25), 2375–2384 (2012). doi:10.1056/NEJMoa1211585
Taggart, D.P.: Stents or surgery in coronary artery disease in 2013. Ann. Cardiothorac. Surg. 2(4), 431–434 (2013). doi:10.3978/j.issn.2225-319X.2013.07.20
Nam, C.W., Mangiacapra, F., Entjes, R., Chung, I.S., Sels, J.W., Tonino, P.A., de Bruyne, B., Pijls, N.H., Fearon, W.F.: Functional SYNTAX score for risk assessment in multivessel coronary artery disease. J. Am. Coll. Cardiol. 58(12), 1211–1218 (2011)
Pijls, N.H., van Schaardenburgh, P., Manoharan, G., Boersma, E., Bech, J.W., Van’t Veer, M., Bar, F., Hoorntje, J., Koolen, J., Wijns, W., de Bruyne, B.: Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER study. J. Am. Coll. Cardiol. 49(21), 2105–2111 (2007)
Nashef, S.A., Roques, F., Michel, P., Gauducheau, E., Lemeshow, S., Salamon, R.: European system for cardiac operative risk evaluation (EuroSCORE) 1. Eur. J. Cardiothorac. Surg. 16(1), 9–13 (1999)
Nilsson, J., Algotsson, L., Hoglund, P., Luhrs, C., Brandt, J.: Comparison of 19 pre-operative risk stratification models in open-heart surgery 1. Eur. Heart J. 27(7), 867–874 (2006)
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf. The authors R. Linder and F. Verheyen declare a potential conflict of interest in terms of the guidelines of the International Committee of Medical Journal Editors because of their affiliation to the Techniker Krankenkasse.
Funding
There was no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous 3 years; no other relationships or activities that could appear to have influenced the submitted work.
Rights and permissions
About this article
Cite this article
Linder, R., Zeidler, J., Verheyen, F. et al. Guidelines versus reality: is coronary stent application in three-vessel disease standard or the exception?. Eur J Health Econ 19, 821–830 (2018). https://doi.org/10.1007/s10198-017-0924-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10198-017-0924-4
Keywords
- Chronic coronary heart disease
- Coronary aortic bypass grafting
- Percutaneous coronary intervention
- Claims data
- Health services research